Saravanapandian, Vidya http://orcid.org/0000-0001-5825-612X
Frohlich, Joel
Hipp, Joerg F.
Hyde, Carly
Scheffler, Aaron W.
Golshani, Peyman
Cook, Edwin H.
Reiter, Lawrence T.
Senturk, Damla
Jeste, Shafali S.
Funding for this research was provided by:
Intellectual and Developmental Disabilities Research Center (U54HD087101-04)
Dup15q Alliance (20182241)
National Institute of Mental Health (T32MH073526)
National Institute of General Medical Sciences (R01 GM111378-01A1)
Article History
Received: 17 September 2019
Accepted: 30 July 2020
First Online: 13 August 2020
Ethics approval and consent to participate
: All EEG studies and analyses were performed with the institutional review board (IRB) approval.
: Not applicable
: Vidya Saravanapandian: no competing interestsJoel Frohlich is a former employee of F. Hoffmann-La Roche Ltd. (October 2016–July 2017).Joerg F. Hipp is an employee of F. Hoffmann-La Roche Ltd.Carly Hyde: no competing interestsAaron W. Scheffler: no competing interestsPeyman Golshani: no competing interestsEdwin H. Cook: no competing interestsLawrence T. Reiter: no competing interestsDamla Senturk: no competing interestsShafali Jeste serves as a consultant for and has received funding from F. Hoffmann-La Roche Ltd. and Yamo Pharmaceuticals